Labeler · US market

Array BioPharma Inc.

Array BioPharma Inc. is a US drug labeler with US FDA registrations covering 2 drug concepts (2 currently active) across 6 packages. It is currently the only active US supplier of 2 drugs.

ACTIVE — US

openFDA · updated weekly

Labeler codes70255

Active drugs2

Registrations2 active / 2

Packages6

Sole supplier of2 drugs

Portfolio2 drugs · US

Every drug concept this labeler has US registrations for, by package count.

Drug	Type	NDCs	Packages	Status
Encorafenib capsule	rx	1	4	SUPPLYING
Binimetinib tablet, film coated	rx	1	2	SUPPLYING

Sole US supplier

Drugs where this labeler is currently the only active US supplier — a single point of failure if it exits.

Binimetinibrx
Encorafenibrx

At a glance

TypeLabeler
Labeler codes70255
Filing names1
Drugs (active)2
Drugs (all time)2
US registrations2
Packages6

Recent events

Shortages, recalls, and registration changes across all filing names.

Mar 8, 2023
RECALLRecall (Class III): MEKTOVI (binimetinib) tablets, 15 mg, 180-count bottle, Rx only, Distributed by: Array BioPharma Inc., a wholly owned s…

Watch this company

Alerts for recalls, exits, and new registrations.

Facility locations, FDA inspections, and parent-company mapping are on the roadmap. Name variants reported to FDA under different spellings are merged into this profile; figures cover the entity across all its filing names.